InGeneron
InGeneron: A multinational biotech firm unlocking patient healing through innovative regenerative therapies.
Founded
2006InGeneron: A multinational biotech firm unlocking patient healing through innovative regenerative therapies.
InGeneron, founded in 2006 and headquartered in Houston, Texas, is a multinational biotechnology company focused on developing innovative regenerative therapies. The company's mission is to unlock the healing potential of each patient's own regenerative cells through novel, safe, and evidence-based treatments. InGeneron offers products and services in regenerative cell separation and diagnostic tools, targeting markets in wound care, aesthetics & reconstruction, orthopedics & spine, cardiovascular, and animal health. The company serves regions including the USA, Europe, and the Middle East.
Notable figures associated with InGeneron include founder and Chairman of the Board Eckhard Alt, CEO Angelo Moesslang, and President Ron Stubbers. The company has achieved significant milestones in cell therapy and stem cell research over its 16 years of operation. With subsidiaries like InGeneron GmbH and InGene, InGeneron has made impactful contributions to the biotechnology field, particularly in enhancing patient care through advanced regenerative medicine solutions.
Companies similar to InGeneron include Endogena Therapeutics, Juventas Therapeutics, SironRX Therapeutics and Histogen.
InGeneron was founded in 2006.
InGeneron's headquarters is located in Houston, TX, US.
InGeneron's most recent funding round was for $23M (USD) in June 2019.
As of Jun 11, 2019, InGeneron has disclosed funding of $51M (USD). Undisclosed round amounts are excluded.
InGeneron has 32 employees as of Feb 5, 2024.
Histogen
histogen.com
